Footer May 10, 2021 If you’d like to stay in touch and receive news from Chimeron Bio, please subscribe below. You may unsubscribe at any time. COMPANY Privacy Policy About Us Company Mission Leadership Team Advisory Board Our Technology Multiplex Particle & Delivery Platform saRNA Biology Our Pipeline News & Publications Careers Contact Quick Links LinkedIn ©2024 Chimeron Bio. All Rights Reserved. https://www.chimeron.com/wp-content/themes/impeka/images/empty/thumbnail.jpg 150 150 Chimeron Bio | Redefining Cancer Therapeutics Chimeron Bio | Redefining Cancer Therapeutics https://www.chimeron.com/wp-content/themes/impeka/images/empty/thumbnail.jpg May 10, 2021 Jun 28, 2024
Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development Apr 16, 2024 Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award Jun 6, 2023 Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors Dec 15, 2022 Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors